8 results
8-K
EX-99.1
DMKPQ
DMK Pharmaceuticals Corp
3 Jan 24
Regulation FD Disclosure
5:00pm
Opioids Synthetics
6 Our mission: To prevent deaths due to poisoning, overdose, and addiction ZIMHI (naloxone) : T o rapidly reverse fentanyl overdose M
8-K
EX-10.2
DMKPQ
DMK Pharmaceuticals Corp
26 May 23
Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals
4:25pm
the development of strategic and operational plans and organizational policies in support of the organization’s mission. The CEO will have general supervision
8-K
EX-99.1
DMKPQ
DMK Pharmaceuticals Corp
16 Nov 20
Adamis Pharmaceuticals Receives a Complete Response Letter from the FDA Regarding ZIMHI
5:23pm
, we believe there is a clear need for higher dose forms of intramuscular naloxone found in ZIMHI. We remain committed to this product and our mission
8-K
EX-99.1
DMKPQ
DMK Pharmaceuticals Corp
25 Nov 19
Adamis Pharmaceuticals Receives a Complete Response Letter from the FDA Regarding ZIMHI
9:16am
with the FDA. We remain committed to this product and our mission to provide physicians and patients access to a higher dose of naloxone. We will take
8-K/A
vndg22h
14 Jun 05
Financial Statements and Exhibits
12:00am
8-K/A
bqv9wqu6561d3z upl
4 Jan 05
Financial Statements and Exhibits
12:00am
10QSB
EX-10.01
zig9qztv4uce6 sew
8 May 98
Quarterly report (small business)
12:00am
- Prev
- 1
- Next